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Summary Photodynamic therapy (PDT) is efficacious in the treatment of small malignant lesions when all
cells in the tumour receive sufficient drug, oxygen and light to induce a photodynamic effect capable of
complete cytotoxicity. In large tumours, only partial effectiveness is observed presumably because of
insufficient light penetration into the tissue. The heterogeneity of the metabolic response in mammary tumours
following PDT has been followed in vivo using localised phosphorus NMR spectroscopy. Alterations in
nucleoside triphosphates (NTP), inorganic phosphate (Pi) and pH within localised regions of the tumour were
monitored over 24-48 h following PDT irradiation of the tumour. Reduction of NTP and increases in P, were
observed at 4-6 h after PDT irradiation in all regions of treated tumours. The uppermost regions of the
tumours (those nearest the skin surface and exposed to the greatest light fluence) displayed the greatest and
most prolonged reduction of NTP and concomitant increase in Pi resulting in necrosis. The metabolite
concentrations in tumour regions located towards the base of the tumour returned to near pre-treatment levels
by 24-48 h after irradiation. The ability to follow heterogeneous metabolic responses in situ provides one
means to assess the degree of metabolic inhibition which subsequently leads to tumour necrosis.
Tumour heterogeneity plays an important role in the treat-
ment of malignancy and therapeutic response. Histo-
pathological or biochemical evaluation of tumour samples
can provide detailed localised information, but since the
sample is evaluated ex vivo, the information may not
accurately reflect the physiologic state of the tissue in situ. Ex
vivo evaluations can only be performed on a sample at one
selected time point, which make studies that monitor the time
course of physiological or pathological change, or that
monitor the course of therapeutic response, difficult and
variable. Futhermore, sampling is usually limited to random
or specifically selected regions of the whole tissue or lesion.
In vivo, nuclear magnetic resonance spectroscopy and imag-
ing can produce multiple, localised samplings over the entire
tissue volume in situ, generating an assessment of tissue
physiology and pathology at a microenvironmental level.
Since the NMR techniques are non-invasive, assessments can
be continuously monitored over the time course of a
therapeutic response.
We report here initial results using localised in vivo 31P
NMR spectroscopy and 'H NMR imaging to assess mam-
mary tumour response to photodynamic therapy (PDT).
PDT consists of the systemic administration of a photosen-
sitising dye, e.g. the hematoporphyrin derivative Photofrin II,
reported to be preferentially retained in tumour tissue
(Kessel, 1986; Schneckenburger et al., 1987; Dougherty &
Mang, 1987), followed by irradiation of the lesion with
visible light. The cytotoxic agent responsible for necrosis is
reported to be the highly reactive singlet oxygen species
formed by the reaction of the excited porphyrin triplet with
dioxygen (Weishaupt et al., 1979; Stenstrom et al., 1980;
Parker, 1987). It has been suggested that tumour cell death
results directly from intracellular damage to the mitochron-
dria (Sandberg & Romslo, 1980; Berns et al., 1982; Gibson &
Hilf, 1983; Hilf et al., 1984), or indirectly, from damage to
tumour vasculature (Selman et al., 1984; Star et al., 1986;
Fingar & Henderson, 1987; Nelson et al., 1988). Either
mechanism may produce decreases in high energy phosphate
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metabolism. Dramatic reduction in average nucleoside
triphosphate (NTP) levels of whole tumours, accompanied by
significant increases in inorganic phosphate (Pi) within the
first hour following PDT irradiation of tumours, were dem-
onstrated using in vivo 31P NMR spectroscopy (Ceckler et al.,
1986; Hilf et al., 1987). At 24h after irradiation, relative
tumour metabolite levels returned to near pre-irradiation
levels, however histological evaluation demonstrated a sharp
demarcation between viable and necrotic regions in the
tumour (Hilf et al., 1987). This depth dependent necrosis,
which developed at long times after irradiation, combined
with the preceding depletion of whole tumour NTP levels,
suggests the presence of a threshold for effective cytotoxicity
based on the extent of light penetration (Wilson et al., 1985).
Below such a threshold, tumour metabolism apparently goes
through transient, sub-lethal, and reversible inhibition. Em-
ploying spatially localised NMR techniques, data presented
here demonstrate the occurrence of physiological
heterogeneity and subsequent development of localised
necrosis in mammary tumours following PDT treatment.
Materials and methods
Tumours andphotodynamic therapy protocols
R3230AC mammary tumours were implanted subcutaneously
in the axillary region of 80-100 g female Fischer rats by the
sterile trochar method (Hilfet al., 1965). Ten to 17 days after
tumour implantation (tumour size approximately 1 cm in
diameter), host animals were administered intraperitoneally
(i.p.) 5 mg kg-' Photofrin II (Quadra Logic Technologies,
Inc., Vancouver, B.C., Canada), a preparation ofhematopor-
phyrin derivative enriched in hydrophobic components. At
24 h after drug administration, the tumours were irradiated
using a Coherent Inova 90 argon pumped tunable dye laser
(Coherent Inc., Palo Alto, California) operated at 630nm
and coupled to a flexible optic fibre fitted with a cylindrical
lens (Optifrin, Grand Island, New York). The output from
the fibre-lens system was focused to produce a 1 cm diameter
beam with an optical power density of 200 mW cm-2 incident
at the tumour surface (which will subsequently be referred to
as the top of the tumour). Tumours were irradiated for
30 min resulting in a total light dose of 360 J cm-2. Prior to
irradiation, the skin over the tumours was shaved. The
tumour temperature was monitored at various depths by
insertion of a needle probe connected to a YSI 4ITD Tele-
Thermometer (Yellow Springs Instruments, Yellow Springs,
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Ohio), and did not rise above 37°C during the irradiation
protocol employed.
NMR studies
NMR studies were performed with an Oxford 2 Tesla, 33 cm
diameter bore horizontal magnet interfaced to a GE CSI II
imaging/spectroscopy system (General Electric NMR
Instruments, Fremont, California). The resonance frequency
was 85.57 MHz for proton, and 34.64 MHz for phosphorus.
31P spectra and 'H images were acquired on tumours prior
to and at selected times after PDT irradiation. The animals
were administered 75 mg kg-' Ketamine hydrochloride and
6 mg kg-' xylazine intramuscularly (i.m.), which maintained
an anaesthetised state for approximately 40 min. For longer
studies, animals were re-injected with reduced doses of anaes-
thetic. The animals were positioned in a plexiglass holder
with the tumour exposed through a slot. An rf coil was
selected from a set of 4-5 turn solenoid NMR coils ranging
from 1 to 2 cm in diameter, and placed around the tumour.
A grounded copper shield was placed around the base of the
tumour to minimise NMR signals from subcutaneous muscle
(Ng & Glickson, 1985). The coil was brought to resonance
with a parallel capacitor and a balanced capacitive matching
circuit. A 4" diameter birdcage coil (Hayes et al., 1985;
Hayes, 1987) was positioned around the entire animal with
the 31P coil in place around the tumour and coupling between
the coils was minimised by orienting the irradiating B, field
orthogonal to each other. The animal holder was then placed
on a cradle which could be vertically adjusted to position the
tumour in the centre of the magnet.
Tumour "P spectra
Localised phosphorus spectra were acquired using a one-
dimensional phase encode technique that generates spectra at
different spatial offsets (Brown et al., 1982; Mareci &
Brooker, 1984). Each spatially selected spectrum represents
signal from an approximately 2 mm thick section perpen-
dicular to the direction of the applied field gradient. A
proton image was used to position the animal and adjust the
field-of-view to encompass a region somewhat larger than the
tumour diameter prior to acquisition of the 31P spectra. The
spatially selective pulse sequence employs a 900 pulse (ap-
proximately 10gs), a 2 ms half-cycle sine-shaped gradient
pulse, a 180°C pulse, followed by a 2ms delay and acquisi-
tion of the second half of the echo. The magnitude of the
gradient is determined by the field-of-view and is incremented
from minimum to maximum in as many steps as the number
of localised sections desired through the tumour. The recycle
time was 5 s, and the spectral width was + 1,000 Hz acquired
with quadrature detection and 4K data points. Typically, 128
transients were acquired per level with total acquisition times
for the spectral set of about 1.5 h. Whole tumour spectra
were acquired with this spin-echo sequence using the same
acquisition parameters, but with the gradient amplitude set
to zero. The magnet field homogeneity was adjusted by shim-
ming on the proton signal with typical 'H linewidths of
20-30 Hz.
Two dimensional Fourier transformation of the data set
yields 3'P spectra as a function of position in the tumour.
The resulting spectra are presented in the absorption mode
with the whole tumour spectrum (no field gradient) as the
phase reference (Barker & Ross, 1987). The 4 ms delay
between the 90°C pulse and acquisition of the echo produces
a 3'P spectrum with intensities weighted somewhat by the
transverse relaxation times. If all relaxation rates were iden-
tical, this weighting would simply reduce the intensity of all
resonances uniformly. The attenuation expected for a 15 ms
T2 is 23% while that for a 40 ms T2 is 10%. Thus, the relative
intensities within a spectrum may be distorted by on the
order of 10-15%. However, this distortion is uniform for all
slices. The inter-slice comparisons that we make are,
therefore, little affected by this consequence of the spatial
localisation scheme.
We note that the recycle delay of 5 s is not long compared
to all T, values in the system, which leads to partially Tl-
weighted "31P spectra. This situation is the norm for in vivo
"P spectroscopy. While resonance intensity distortions result
from this acquisition in a partially saturated mode as for the
T2 effects, these should be the same for all slices, and, thus,
not affect the inter-slice comparisons.
Tumour 'H spectra
Whole tumour and localised proton spectra were acquired
with the same protocol and coil as for 3'P spectra. The
acquisition parameters were adjusted to account for the
higher signal-to-noise and the untuned probe. The recycle
time was 2 s, the spectral width was ± 2,000 Hz and 2K data
points were collected. The 'H 900 pulse width was approxi-
mately 20lss in the 3'P coil and four transients per level were
acquired.
Proton images
Proton images were acquired using a standard spin-echo
phase-encode sequence. TI-weighted images were acquired
using a recycle time (TR) of400 ms and echo delay time (TE)
of 16ms. T2-weighted images were acquired using a TR of
2,200 ms and a TE of 90 ms. For all images the slice thick-
ness was 2 mm, the field of view 50 x 50 mm, and two
acquisitions per phase encode step were collected.
pH determinations
The intracellular pH was determined from the chemical shift
of the inorganic phosphate peak in the 3'P spectra (Gadian et
al., 1982). The phosphocreatine peak is typically used as the
reference peak since its chemical shift is insensitive to pH in
the physiologic range. However, since the level of phos-
phocreatine in these mammary tumours was often undetect-
able, the water 'H resonance was used as the "P chemical
shift reference (Ackerman et al., 1981). Whole tumour and
localised proton spectra were acquired prior to the acquisi-
tion of the "P spectra.
Data analysis andpresentation
The "P spectra were fit using the routine GEMCAP supplied
with the GE system software. This routine permits interactive
adjustment of peak width, height, and position to generate a
fit for each peak in the spectrum assuming a Lorentzian
lineshape. The difference spectra between the acquired and
the calculated spectrum were within the noise level. Peaks
were not fit if peak heights were less than twice the noise
level.
Resonance assignments are summarised in Figure la. The
NTP and NDP peaks are predominantly due to ATP and
ADP respectively (Rodrigues et al., 1988). Contributions
from other nucleoside triphosphates, such as GTP, are not
resolved under our experimental conditions. Therefore, when
discussing data obtained by NMR we refer to these peaks as
NTP and NDP. We refer to ATP when discussing cellular
metabolism. The P-NTP peak at approximately 20 p.p.m.
upfield from Pi, is used as a measure of NTP levels in tissues
because this resonance has no contribution from NDP. Data
for metabolite levels are presented as ratios of the peak areas
for P-NTP and Pi. Measurement of absolute metabolite con-
centrations was not attempted because no appropriate inten-
sity standard was employed during spectral acquisition.
Assignment of localised "P spectra to specific levels within
the tumour was based on the corresponding localised 'H
spectra which had the obvious advantage of a high signal-to-
noise ratio. The first proton spectrum of the data set that
showed a clearly resolved water peak was assigned to the
base of the tumour and sequential spectra were then assigned
to the adjacent levels in the tumour. The same spatial assign-
ments were made for the 3'P localised spectral data sets.
Three to five spectra from the localised "P data sets con-918 T.L. CECKLER et al.
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Figure 1 Whole tumour and localised 31P NMR spectra acquired
prior to and at selected times after photodynamic therapy irradia-
tion. Peak assignments are (i) phosphomonoesters, (ii) inorganic
phosphate, (iii) phosphodiesters, (iv) phosphocreatine, (v) y-NTP,
(vi) a-NTP, a-NDP, (vii) P-NTP. a, Whole tumour spectra. Times,
in hours, after irradiation are indicated on each spectrum. b,
Localised spectra acquired prior to PDT irradiation. The field of
view was 16 mm so that each spectrum represents signal from a
2 mm slice taken normal to the direction of incident light. Levels
corresponding to regions of the tumour are labelled with letters
A-F. Signal from tumour is seen mostly in levels B-E. Level F
corresponds to the top of the tumour, or the region closest to the
incident light source. c, localised spectra acquired at 1.5-3 h,
d, at 5.5-7 h, and e, at 22.5-24 h after PDT irradiation.
tained sufficient signal for analysis depending on the size of
the tumour and position in the field of view. There were only
two cases in which five levels could be assigned. In these
cases, the spectra corresponding to the two levels furthest
from the top of the tumour were averaged. The data were
put into time blocks corresponding to control (i.e. prior to
photo-irradiation), 0.3-4 h post irradiation, 4-7 h post
irradiation and 19-29 h post irradiation. A total of nine
animals were studied with a minimum of six in each time
block. An additional four animals treated under the same
protocol were included for the whole tumour data and a
minimum of four animals per time point are presented.
The removal and repositioning of the host animal between
each spectroscopic study may result in some overlap of
regions from one set of localised spectra to another. How-
ever, based on the position of the signal within the field of
view, the uncertainty is estimated to be less than half the
width of one section, or approximately 1 mm.
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Results
Effect ofPDT on phosphate metabolites andpH using
localised spectroscopy ofa representative tumour
Representative whole tumour and localised spectra obtained
from a single tumour are shown in Figure 1. Some broaden-
ing in the localised spectra is apparent and may be due to
gradient induced eddy-current effects. A compromise in the
echo delay time was made to minimise eddy-current effects
and loss of signal because of transverse magnetisation decay.
Decreased signal intensity in localised spectra corresponding
to the top of the tumour is due to smaller tissue volumes.
Decreased intensity in spectra from the base of the tumour
may result from smaller tissue volume and a decreased
excitation and reception sensitivity outside the r.f. coils. The
level of NTP in the whole tumour spectra (Figure la)
decreased but remained detectable at all times after irradia-
tion. The localised spectra demonstrated a more extensive
depletion ofNTP and a greater increase in Pi levels in the top
regions of the tumour compared to changes observed in the
whole tumour spectra.
Systematic differences in Pi between tumour levels observed
in the localised spectra developed by 3 h and were main-
tained, though to a lesser extent, at 24 h after irradiation.
Relative changes in Pi levels appeared to be of greater mag-
nitude than alterations in the amounts of NTP. Although the
NTP levels measured in different regions of the tumour differ
prior to irradiation, all were reduced to approximately the
same relative level by 3 h after irradiation. Differences in
NTP between tumour levels were small except in the top-
most region of the tumour, which showed an almost com-
plete loss of NTP.
0-NTP to Pi ratios based on peak areas as a function of
time after irradiation are presented in Figure 2 for the whole
tumour (dashed lines) and from this same tumour for the
localised regions (localised spectra shown in Figure 1). The
levels are labelled in order from A at the base, i.e. furthest
from the light source. (When level F could be assigned, the
data were averaged with level E). In experiments not present-
ed, the early metabolic response to PDT is less in skin than
tumour tissue; therefore, averaging levels E and F yields an
underestimate of the metabolic changes in the tumour tissue.
The intensity ratios for the whole tumour spectra approxi-
mate the averages of the data obtained from the localised
regions of the tumour.
The calculated pH prior to and after PDT for the whole
tumour (dashed line) and the localised levels in this repre-
sentative tumour are presented in Figure 3. The top region of
the tumour became more acidotic than the lower regions by
3 h after irradiation. The pH determined from the NMR
spectra returned to pretreatment values in all regions of the
tumour by 24 h after irradiation.
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Figure 2 Alterations in Pi and NTP levels following PDT
irradiation represented as the ratio of P-NTP to Pi (% of initial).
Time points correspond to midpoints in the acquisition period.
(-O-) whole tumour data; (---) tumour level B; (-O-)
tumour level C; (-i -) tumour level D; (-O-) tumour level E
and F averaged.
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Figure 3 Calculated pH values as a function of time after PDT
irradiation. Times are at the midpoint of the acquisition period.
(-0-) whole tumour data; (-0-) tumour level B; (-0
tumour level C; (-U-) tumour level D; (-O-) tumour level E
and F averaged.
Effects ofPDT on proton images ofa representative tumour
T2-weighted proton images acquired from the tumour de-
scribed above prior to irradiation, and at times immediately
before acquisition of the localised 31P spectra, are shown in
Figure 4. T,-weighted images were of uniform intensity
throughout the tumour before and at all times after PDT
irradiation and are not presented. The high intensity region
observed in the centre of the tumour in the T2-weighted
images prior to and following irradiation is attributable to a
region of spontaneously developed necrosis. As published
previously (Hilf et al., 1987), spontaneous central tumour
necrosis retains more cellular 'ghosts' or remnants. PDT-
induced necrosis is more destructive of the cells and connec-
tive tissue components, derived from adjacent areas of
connective tissue, more readily infiltrate the necrosis region.
No apparent changes in the proton images as a result of
treatment were seen until 24 h after irradiation, at which time
high signal intensity was observed in the uppermost region of
the tumour, consistent with increased water content and
decreased viscosity indicating cell decomposition and necrosis
(Rodrigues et al., 1988; Narase et al., 1986a). That the proton
magnetic image does not show an early change while the 31P
NMR spectra do reflects the fact that the complicated sum of
effects that control the 'H effect relaxation rates in the tissue
are not altered by the therapy even though the NTP levels are.
Combined resultsfor whole tumour and localised3'P-NMR
spectroscopy
Tumour phosphate metabolite levels were determined prior
to and at selected times after PDT irradiation. All animals
were exposed to the same treatment protocol. Figure 5
depicts the whole tumour P-NTP/Pi ratios. A significant
reduction in this ratio occurs from 2 to 7 h after PDT
irradiation compared to pre-irradiation values (P <0.05 by
the Student's t-test comparing control vs treated tumours).
The combined data for the P-NTP/Pi ratios obtained for the
localised spectra are shown in Figure 6. At 0-4 h post
irradiation, the ,-NTP/Pi ratio decreases to approximately
the same level in all regions of the tumour. After this time,
an apparent heterogeneity in the response is evident, becom-
ing more marked at 24 h post irradiation. Statistical analysis
of these data by the Student's t-test for pair-wise com-
parisons demonstrates that the ,-NTP/Pi ratios for all
tumour levels in the 0.3-4 h time block are significantly
reduced when compared to controls (P <0.05). At 4-7 h
after PDT irradiation, reduction in the P-NTP/Pi ratio was
significant only when level E was compared to control levels.
No significant differences were found in the ratios between
0.3-4 h vs 4-7 h PDT groups. At 24 h after PDT irradia-
tion, the level E P-NTP/Pi ratios remained significantly
reduced compared to all pre-treatment control levels. Inter-920 T.L. CECKLER et al.
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Figure 5 Effects of PDT on whole tumour P-NTP/P, ratios.
Treatment and spectral acquisition parameters are described in
the text. Each bar represents the mean P-NTP/P, ratio obtained
from 5-13 tumours prior to or at selected times after PDT
photoirradiation. Bars are the s.e.m.
1.6 -
1.2
-
Figure 4 T2-weighted proton NMR images acquired a, before,
b, 1 h after, c, 5 h after, and d, at 22 h after PDT irradiation. The
tumour dimensions are 10 mm by 12 mm. (TR 2200 ms TE 90 ms,
FOV 50 x 50 mm).
level comparisons at 24 h after PDT provided a significant
difference only between level B and level E. The data, taken
together, indicate that PDT induces a prolonged decrease in
P-NTP/Pi ratios near the top of the tumour, suggesting
irreversible damage not apparent in deeper tumour tissue
levels where metabolite ratios return to near pre-treatment
values by 24 h post-irradiation.
Discussion
The efficacy of PDT as a cancer treatment depends on three
known and variable components: the concentration and dis-
tribution of photosensitising drug in the irradiated tissue, the
incident photon flux delivered to the tissue, and the tissue
oxygen concentration. Within isolated microenvironments of
a lesion, formation of singlet oxygen, reportedly a necessary
precursor of resultant cytotoxicity, may vary. This variability
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Figure 6 Effects of PDT on P-NTP/Pi ratios obtained from
localised 3'P-NMR spectra on tumours. Each bar represents the
mean P-NTP/Pi ratio obtained for individual tumour slices from
four to nine tumours; level B, innnermost slice; levels C, D and E
obtained from tumour slices progressively proximal to the top of
the tumour. Ratios were calculated from spectra acquired in time
blocks prior to (0 time) and at selected periods after PDT irradia-
tion, 0.3-4h, 4-7h, 19-29h. Bars are the s.e.m.NMR ASSESSMENT OF TUMOUR HETEROGENEITY 921
is compounded by the heterogeneity of the lesion, consisting
of viable well oxygenated cells at the periphery and regions
of hypoxic cells towards the centre, where spontaneous nec-
rosis may arise. The amount of activating light that pene-
trates the tissue depends on the wavelength and tissue depth.
Thus, results obtained as averages across the entire lesion
may be inaccurate indicators of localised events.
The use of localised 31P NMR spectroscopy provides one
means to detect heterogeneous responses within a single
lesion. The technique permits use of an implicit control, i.e.,
measurements on the same tumour regions in situ before and
after therapeutic intervention. Examination of spectra
obtained from the whole tumour demonstrated decreases in
tumour NTP levels concomitant with increases in Pi during
the first hour following irradiation of the tumour. This result
is consistent with rapid metabolic inhibition. Significant
decreases in high energy metabolites were observed between 2
and 7 h post irradiation (Figure 6), followed by a gradual
return to near pretreatment levels by 30-48 h, a finding
which is in agreement with other investigators (Naruse et al.,
1986b; Chopp et al., 1987, 1990). The 31p spectra taken from
localised 2 mm slices of the tumour show that the high
energy phosphates decline throughout the tumour mass
shortly following photoradiation. This general decline in
NTP throughout the tumour mass is consistent with earlier
whole tumour studies (Ceckler et al., 1986; Hilf et al., 1987).
However, subsequent recovery is shown to be slice-depth
dependent. The development of this heterogeneous metabolic
response becomes apparent at a time when the average data
for the whole tumour show a relatively constant P-NTP/Pi
ratio.
The localised spectra presented here require acquisitions
over 1.5 h to provide sufficient 3lP signal from the 0.2 cm3
tissue sections. Although this is a relatively long time over
which to average a response (4-5 times longer than for the
whole tumour data), significant changes are evident. These
metabolic responses precede any detectable effect on tumour
size (Gibson et al., 1990).
We have presented the data as the ratio of,-NTP to Pi
here and previously (Ceckler et al., 1986; Hilf et al., 1987).
Since both NTP and Pi levels change in response to PDT,
this choice of presentation may amplify or diminish the
actual response. Though this presentation may not be ideal,
alternatives require greater signal-to-noise ratios than
available and it does provide a useful indicator of metabolic
status. Since Pi is the product of ATP hydrolysis (Hilf et al.,
1986; West-Jordan et al., 1987), the total phosphorus would
be conserved in a closed system. However, total phosphate
conservation may be compromised by circulatory removal of
Pi from necrotic areas in the tissue, or by infiltration by
macrophages and lymphocytes. A decrease in total observ-
able phosphates, consistent with circulatory washout from
necrotic regions, is evident in the spectra acquired at 24 h
after irradiation where decreases in signal intensity were
observed with no observable reduction in tumour size. How-
ever, it is acknowledged that vascular congestion and stasis
are common following PDT. Nevertheless, the degree of cell
damage, i.e., necrosis, is much more rapid than would
gradually occur during the developing necrosis of the tumour
evoked by vascular deprivation.
The change in pH observed for different slices in the
tumour parallel the heterogeneous changes for the phosphate
metabolites up to 7 h after irradiation. However, at 24 h
post-irradiation, the pH determined at each level had
returned to pretreatment values. Though the mechanistic
details of PDT action remain unclear at this point, one
possibility demonstrated in vitro is that the therapy inhibits
aerobic mitochrondrial ATP production. A consequence of
dependence on anaerobic glycolytic production of ATP
would be increased production of lactic acid, leading to a
decrease in pH, which was observed. Decreases in pH
between 1 to 7 h and the return to pretreatment values at
24 h following PDT irradiation have been consistently
observed by us for whole tumour 31P NMR (Gibson et al.,
1989). The finding that the pH in all regions of the tumour
returns to pretreatment values while there still exists
heterogeneity in the phosphate metabolite levels at 24 h after
irradiation, i.e. NTP levels do not return to control values
but the Pi signal was present throughout the time period
investigated, implies some uncoupling between these two
parameters.
Proton NMR images of treated tumour at 24 h after PDT,
Figure 4, clearly demonstrate an area of high intensity in the
region nearest the light source extending to a maximum
depth of about 2-3 mm. The presence of high intensity
regions in a T2-weighted image corresponds to an increase in
T2, which may result from an increase in water content or an
increase in water mobility that is consistent with necrosis.
These high intensity regions observed in situ by 'H NMR
were confirmed to arise from necrosis regions by gross histo-
logical evaluation of excised tumours. Within this necrotic
region, a reduction of 0.3-4 pH units and a 3-fold increase
in Pi was observed at 4-7 h after PDT irradiation. Necrosis
detected by NMR imaging became apparent at times later
than the most dramatic alterations in pH and metabolite
concentrations observed using 31P spectroscopy.
The changes in 31P signal intensities reported here were not
corrected for possible changes in 31P relaxation times. The 'H
images of tumours before and after PDT irradiation suggest
that there are increases in T2 relaxation times in regions of
developing necrosis, though T, changes are less apparent.
Thus, the 31P signal intensities from spectra acquired with a
spin-echo sequence under partially saturating conditions may
reflect differential changes in the 31P NMR relaxation times
caused by changes in the effective microdynamic viscosity.
The decrease in apparent viscosity in necrotic areas suggested
by the proton image should increase the observed signal
intensities with the short T2 signals like NTP, which would be
affected the most. However, the NTP intensity in these
regions is decreased in spite of these possible changes. Thus,
the comparisons made are not invalidated by possible
changes in the 31P relaxation times caused by the treatment.
The studies presented here show that there are several
consequences of the photosensitisation events of PDT, which
results in depth dependent metabolic responses within the
tumour. A primary response may be direct tumour cell
damage in the regions of the tumour where light intensity is
highest. Cells in regions where the light is increasingly
attenuated may undergo sublethal damage, a period of quie-
scence followed by repair and subsequently, a return to
normal metabolic activity 24-48 h after irradiation. Vascular
damage may also play a role in the long term metabolic
response with the collapse of blood vessels over time compro-
mising flow and perfusion in the top regions of the tumour.
Blood vessels at greater depths in the tumour may become
reversibly damaged allowing for repair and re-establishment
of blood flow to the lower regions of the tumour.
The data presented here also suggest that there are
significant metabolic changes occurring at early times follow-
ing PDT that may be predictive of subsequent necrosis. The
combination of increases in P, levels and decreases in pH
appear to be the most predictive markers of subsequent
necrosis following PDT. These data taken together with our
previous study (Hilf et al., 1987) show that the changes in
phosphate metabolites resulting from PDT preceed necrosis
at the top of the tumours, when detected either via proton
imaging or by histological examination, and changes in
tumour size, results that agree with those of Dodd et al.
(1989). The fact that some regions of the tumour show
reversible metabolic changes suggests that the damage in
these regions was sub-lethal and repairable; in Figure 2, level
B, the P/Piratio increases to 180% of control, possibly as a
result of induction of repair mechanisms that would increase
metabolic activity. A question remains whether the metabolic
alterations can be attributed to either direct cell damage,
vascular damage, or both. There is a need to study metabolic
responses along with blood flow and perfusion to provide
information on the mechanism(s) of PDT. The detection of
early physiologic changes following therapy may be useful in
the development of predictive indices of treatment efficacy922 T.L. CECKLER et al.
and may be correlatable to subsequent tumour growth con-
trol.
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